Monthly Archives: March 2015

Page 4 of 41234

After years of research, developed Ward, Diegelmann Bowlin and a versatile and robust hemostatic specifically specifically suited to treat the tremendously complex wounds of war under very harsh environments. WoundStat is both very absorbent and supporters who help to stop the bleeding quickly and simultaneously facilitates blood clotting.

About VCU and the VCU is is Virginia Commonwealth University the largest university in one in Virginia and one of the 100 best universities in the country in sponsored research. Located on two downtown campuses in Richmond, enrolls VCU more than 30,000 students in nearly 200 certificate and degree programs in the arts, sciences and humanities. Sixty – three of the programs are unique in Virginia, many of them crossing to disciplines of VCU the 15 schools and one college. MCV Hospitals and the health sciences schools , Virginia Commonwealth University compose the VCU Medical Center, one of the nation’s leading academic medical centers.. Continue reading

Cardium InnerCool Therapies subsidiary is a San Diego-based medical technology company in the emerging field of temperature modulation therapy rapidly and controllably cool the body cell death cell death and damage caused by acute ischemic events such as heart attack or stroke, and potentially to lessen or prevent associated injuries such as adverse neurological outcomes.

Supported by the William T. Sweeney Memorial Fund and the IADR Dental Materials Group, is the oldest of the 16 IADR Distinguished Scientist Awards and consists of one prize and a plaque. The award honors Dr. Wilmer Souder, the driving force in establishing the Dental Section at the National Bureau of Standards and is designed to promote interest in dental materials research. It is one of the highest honors bestowed by IADR. Continue reading

Orth team driving performance measured apneic subjects before treatment and then two and 42 days after initiation of treatment.

The results in November the ERJ is clear: Not only were attention and alertness improved after 42 days of treatment, as well as sleepiness scores and polysomnographic traces, but a safe driving performance can be seen even before the other improvements. The comparative accident rate declined sharply as treatment began. With these results underlines the German team qualities qualities of the simulator in the study, which is suited to be particularly well suited to this type of investigation. Continue reading

The point – of-care genetic test is used in the study, is an innovation in medicine , overcoming many of the previous obstacles that had prevented routine clinical genetic tests. The test presented:.

About 25 % of Caucasians and 40 % of Asians have the genetic variant CYP2C19* 2, a patient at risk of not responding well to clopidogrel , the standard antiplatelet drug after stent given method. Those tested were found to have been administered to bear the at-risk genetic variant an alternative drug prasugrel . Continue reading

Page 4 of 41234